TRCT
CLNN icon

Tower Research Capital (TRC)’s Clene CLNN Stock Holding History

Tower Research Capital (TRC)’s Portfolio CLNN Stock Details CLNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-444
Closed -$2.19K – 5264
2026
Q1 		$2.19K Buy
+444
New +$2.27K ﹤0.01% 4525
2025
Q3 		– Sell
-1,153
Closed -$4.51K – 5261
2025
Q2 		$4.51K Sell
1,153
-1,140
-50% -$3.71K ﹤0.01% 4316
2025
Q1 		$7.06K Buy
2,293
+1,621
+241% +$7.34K ﹤0.01% 3986
2024
Q4 		$3.57K Sell
672
-281
-29% -$1.41K ﹤0.01% 4637
2024
Q3 		$4.38K Sell
953
-15
-2% -$79 ﹤0.01% 4568
2024
Q2 		$6.89K Buy
968
+476
+97% +$3.56K ﹤0.01% 4525
2024
Q1 		$4.18K Sell
492
-814
-62% -$7.04K ﹤0.01% 4720
2023
Q4 		$7.76K Sell
1,306
-37
-3% -$322 ﹤0.01% 4581
2023
Q3 		$13.3K Buy
1,343
+601
+81% +$8.33K ﹤0.01% 3803
2023
Q2 		$13.1K Buy
742
+220
+42% +$4.29K ﹤0.01% 3808
2023
Q1 		$12K Buy
522
+55
+12% +$1.43K ﹤0.01% 4059
2022
Q4 		$9K Sell
467
-252
-35% -$5.85K ﹤0.01% 4175
2022
Q3 		$40K Buy
719
+507
+239% +$33.6K ﹤0.01% 3349
2022
Q2 		$11K Buy
212
+67
+46% +$3.74K ﹤0.01% 4359
2022
Q1 		$11K Sell
145
-141
-49% -$8.53K ﹤0.01% 4153
2021
Q4 		$23K Buy
286
+152
+113% +$16.3K ﹤0.01% 3500
2021
Q3 		$18K Buy
134
+125
+1,389% +$21.3K ﹤0.01% 3810
2021
Q2 		$2K Sell
9
-2
-18% -$422 ﹤0.01% 5023
2021
Q1 		$3K Buy
+11
New +$2.41K ﹤0.01% 4882

Other funds holding CLNN

EAM
Empery Asset Management New York $86.5M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LCM
Lunt Capital Management Holladay, Utah $273M AUM 15.42% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s CLNN Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Clene (CLNN) in Q2 2026, closing a stake of 444 shares — an estimated $2.19K sold.

Tower Research Capital (TRC) first reported a position in CLNN in Q1 2021 and held it in 19 quarters. The position peaked at $40K in Q3 2022. 21 funds tracked by Wall St. Rank hold CLNN as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Clene position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 444 Clene shares in Q2 2026, an estimated $2.19K.
  • Tower Research Capital (TRC) first reported a position in Clene in Q1 2021 and held it in 19 quarters.
  • Tower Research Capital (TRC)'s Clene position peaked at $40K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Clene as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.